<DOC>
	<DOCNO>NCT01284114</DOCNO>
	<brief_summary>The purpose study determine whether aliskiren effective treatment blood pressure , hear function , renal function elderly hypertensive chronic kidney disease ( CKD ) patient .</brief_summary>
	<brief_title>Effects Aliskiren Elderly Hypertensive Chronic Kidney Disease ( CKD ) Patients</brief_title>
	<detailed_description>Chronic kidney disease ( CKD ) report affect 11 % population . This number much high elderly population may high 30 % . CKD independent risk factor cardiovascular disease ( CVD ) . This call `` Cardio-renal Continuum '' . The renin-angiotensin-aldosterone system ( RAS ) play pivotal role cardiovascular renal function . The increased oxidative stress activate RAS vascular endothelium one important factor development Cardio-renal Continuum . The blockade RAS angiotensin I convert enzyme inhibitor ( ACEIs ) and/or angiotensin receptor blocker ( ARBs ) report ameliorate renal disease CVD ; however , completely suppress RAS , lead reactive rise plasma renin activity ( PRA ) . Aliskiren , oral direct renin inhibitor , effective essential hypertension reduce PRA , result complete suppression RAS ; however , little known effect aliskiren heart kidney function elderly hypertensive CKD patient . In study , assess efficacy aliskiren heart kidney function elderly hypertensive CKD patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Clinical diagnosis Chronic kidney disease Clinical diagnosis Hypertension ( Blood pressure &gt; =140/90mmHg ) Elderly people ( &gt; =65 year old ) The patient already take aliskiren The patient receive hemodialysis peritoneal dialysis The patient take cyclosporin The patient hyperkalemia ( &gt; =5.5mEq/ml ) Severe heart failure ( &gt; =NYHA class III ) Insulin dependent diabetic mellitus poor control insulin independent diabetic mellitus ( &gt; =HbA1c 9.0 &amp; ) Severe liver dysfunction ( five fold increase AST ALT standard value )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Elderly chronic kidney disease</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Aliskiren</keyword>
</DOC>